MarginsXMarginsX
Home › Markets › Health Care › DRUG

Bright Minds Biosciences Inc. (DRUG)

DRUG trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$22.61
-2.16% on the day
Market cap
$222.0M
Micro cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerDRUG on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryCanada
IPO yearNot reported by the screener
SEC CIK0001827401
SEC industry codePharmaceutical Preparations
Incorporated inBC
Canadian listingCSE: DRUG

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
114.5 months
82.9M CAD cash at September 30, 2025
Share count, 1 year
+68.8%
2024-09-30 to 2025-09-30 · +117.0% over 3 years
Going-concern doubt
No
40-F filed December 23, 2025
Insider net buying, 12 months
-$9.8M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.40-F 2025-12-23
Cash and burn82.9M CAD cash; operating cash flow -2.2M CAD a quarter.Report 2025-09-30
Shares outstanding7,635,789 (2025-09-30); 4,524,087 a year earlier; 17,592,359 three years earlier. 3y figure adjusted for split (1-for-5 overall); the newest SEC cover-page count is from 2025-09-30; shares issued since then are not in these figures.Cover page 2025-09-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-01-09
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDe Visser Gray LLP, Vancouver, CanadaPCAOB Form AP 2026-01-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $9.8M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-09-30
Not filed-12.2M CAD-8.7M CAD82.9M CADNo debt tagsNeeds four quarters40-F 2025-12-23
FY 2024
2024-09-30
Not filed-2.8M CAD-1.9M CAD5.7M CADNo debt tagsNeeds four quarters20-F 2024-12-31
FY 2023
2023-09-30
Not filed-7.4M CAD-7.0M CAD6.7M CADNo debt tagsNeeds four quarters20-F 2024-12-31
FY 2022
2022-09-30
Not filed-15.0M CAD-13.6M CAD11.6M CADNo debt tagsNeeds four quarters20-F 2024-12-31
FY 2021
2021-09-30
Not filed-8.7M CAD-7.3M CAD19.8M CADNo debt tagsNeeds four quarters20-F 2023-12-29
FY 2020
2020-09-30
Not filed-480K CAD-288K CAD800K CADNo debt tagsNeeds four quarters20-F 2022-12-29

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in CAD.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B5
424B52026-01-09
Latest annual report
FORM 40-F
40-F2025-12-23
Latest quarterly / interim6-K2026-11-02

Source: SEC EDGAR submissions feed, 182 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.5%
1 month-55.0%
3 months-70.4%
Year to date-70.4%
1 year-60.4%
From 52-week high-75.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
BCYCBicycle Therapeutics plc$3.18-5.64%$222.9M
IMRXImmuneering Corporation$3.52-5.12%$228.0M
VNDAVanda Pharmaceuticals Inc.$3.81-4.51%$230.4M
VOGXVogenx Inc$14.38-13.74%$213.6M
ACIUAC Immune SA$2.09-1.88%$212.7M
YARWYarrow Bioscience Inc.$13.93-22.74%$212.2M
AMRNAmarin Corporation plc$11.31-0.62%$233.4M
CYPHCypherpunk Technologies Inc.$1.93+2.94%$207.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier